idazoxan has been researched along with Alloxan Diabetes in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berrocoso, E; Borges, GDS; Mico, JA; Torres-Sanchez, S | 1 |
| Authier, N; Bertrand, M; Chapuy, E; Chenaf, C; Courteix, C; Eschalier, A; Gabriel, C; Libert, F; Marchand, F; Mocaër, E | 1 |
| Aubel, B; Bourgoin, S; Farré, A; Hamon, M; Kayser, V; Mauborgne, A | 1 |
| Banyasz, T; Kovacs, T; O'Donnell, JM | 1 |
| Bitar, MS; Pilcher, CW | 1 |
| Cattaneo, AG; Doxey, JC; Efendic, S; Ostenson, CG | 1 |
6 other study(ies) available for idazoxan and Alloxan Diabetes
| Article | Year |
|---|---|
Opioid and noradrenergic contributions of tapentadol to the inhibition of locus coeruleus neurons in the streptozotocin rat model of polyneuropathic pain.
Topics: Action Potentials; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dose-Response Relationship, Drug; Idazoxan; Locus Coeruleus; Male; Naloxone; Neural Inhibition; Neurons; Pain Measurement; Rats; Tapentadol | 2018 |
Agomelatine: a new opportunity to reduce neuropathic pain-preclinical evidence.
Topics: Acetamides; Adrenergic alpha-2 Receptor Antagonists; Amines; Animals; Antineoplastic Agents; Constriction, Pathologic; Cyclohexanecarboxylic Acids; Diabetes Mellitus, Experimental; Disease Models, Animal; Excitatory Amino Acid Antagonists; Gabapentin; gamma-Aminobutyric Acid; Hyperalgesia; Hypnotics and Sedatives; Idazoxan; Male; Motor Activity; Neuralgia; Organoplatinum Compounds; Oxaliplatin; Pain Measurement; Rats; Rats, Sprague-Dawley; Thiophenes | 2017 |
Antihyperalgesic effects of cizolirtine in diabetic rats: behavioral and biochemical studies.
Topics: Analgesics, Non-Narcotic; Analysis of Variance; Animals; Behavior, Animal; Body Weight; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Drinking; Drug Interactions; Glycemic Index; Hyperalgesia; Idazoxan; Infusion Pumps, Implantable; Male; Pain Measurement; Pain Threshold; Paroxetine; Pyrazoles; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Spinal Cord; Streptozocin; Time Factors | 2004 |
Altered thermoregulatory responses to clonidine in streptozotocin-diabetic rats.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Body Temperature Regulation; Clonidine; Diabetes Mellitus, Experimental; Idazoxan; Male; Rats; Rats, Wistar; Streptozocin; Time Factors; Yohimbine | 1996 |
Diabetes attenuates the response of the lumbospinal noradrenergic system to idazoxan.
Topics: Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Body Weight; Clonidine; Diabetes Mellitus, Experimental; Gene Expression Regulation; Idazoxan; Male; Norepinephrine; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; RNA, Messenger; Spinal Cord; Tritium | 2000 |
Alpha-adrenoceptors and insulin release from pancreatic islets of normal and diabetic rats.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Brimonidine Tartrate; Diabetes Mellitus, Experimental; Dioxanes; Female; Glucose; Idazoxan; Insulin; Islets of Langerhans; Male; Phentolamine; Prazosin; Quinoxalines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Streptozocin; Yohimbine | 1989 |